Skip to main content
. 2024 May 24;103(21):e38292. doi: 10.1097/MD.0000000000038292

Figure 1.

Figure 1.

Overall survival curves according to RDI group (A); overall survival curves of patients who received sufficient RDI of adjuvant S-1 chemotherapy, insufficient RDI of adjuvant S-1 chemotherapy, and no adjuvant S-1 chemotherapy (B); and relapse-free survival curves according to RDI group (C) in patients who have undergone resection of pancreatic ductal adenocarcinoma. RDI = relative dose intensity.